Merck & Co., Inc. (MRK) operating KPIs
MRKNYSEPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Aug 7, 2026Score 9/30242% above fair value
$146.33+5.40 (+3.83%)
Close on Oct 29, 2026Market cap $361.02BP/E 117.1Yield 2.24%
Merck dB Balance Sheet — Total Assets ($M) ($M)
Postgres DB financial_values (via lib/db.py)
Latest, FY2025
136,866
Period ended Dec 31, 2025
Change on a year earlier
+16.9%
117,106 in FY2024
History
18 years
Since FY2008
Sources
17
Documents cited below
Annual history
Hover a value to see the sentence it was read from; calculated values show their formula
| Period | Ended | DB Balance Sheet — Total Assets ($M) ($M) | Year on year | Source |
|---|---|---|---|---|
| FY2025 | Dec 31, 2025 | 136,866 | +16.9% | Form 10-K (filed 2026-02-24) ↗ |
| FY2024 | Dec 31, 2024 | 117,106 | +9.8% | Form 10-K (filed 2025-02-25) ↗ |
| FY2023 | Dec 31, 2023 | 106,675 | -2.3% | Form 10-K (filed 2024-02-26) ↗ |
| FY2022 | Dec 31, 2022 | 109,160 | +3.3% | Form 10-K (filed 2023-02-24) ↗ |
| FY2021 | Dec 31, 2021 | 105,694 | +15.4% | Form 10-K (filed 2022-02-25) ↗ |
| FY2020 | Dec 31, 2020 | 91,588 | +8.5% | Form 10-K (filed 2021-02-25) ↗ |
| FY2019 | Dec 31, 2019 | 84,397 | +2.1% | Form 10-K (filed 2020-02-26) ↗ |
| FY2018 | Dec 31, 2018 | 82,637 | -6.0% | Form 10-K (filed 2019-02-27) ↗ |
| FY2017 | Dec 31, 2017 | 87,872 | -7.9% | Form 10-K (filed 2018-02-27) ↗ |
| FY2016 | Dec 31, 2016 | 95,377 | -6.2% | SEC Filing ↗ |
| FY2015 | Dec 31, 2015 | 101,677 | +3.6% | SEC Filing ↗ |
| FY2014 | Dec 31, 2014 | 98,167 | -7.1% | Form 10-K (filed 2016-02-26) ↗ |
| FY2013 | Dec 31, 2013 | 105,645 | -0.5% | Form 10-K (filed 2014-02-27) ↗ |
| FY2012 | Dec 31, 2012 | 106,132 | +1.0% | Form 10-K (filed 2013-02-28) ↗ |
| FY2011 | Dec 31, 2011 | 105,128 | -0.6% | Form 10-K (filed 2012-02-28) ↗ |
| FY2010 | Dec 31, 2010 | 105,781 | -5.8% | Form 10-K (filed 2011-02-28) ↗ |
| FY2009 | Dec 31, 2009 | 112,314 | +138.0% | Form 10-K (filed 2011-02-28) ↗ |
| FY2008 | Dec 31, 2008 | 47,196 | – | Form 10-K (filed 2010-03-01) ↗ |
Breakdown
What makes up db balance sheet — total assets ($m)
- Cash and Cash Equivalents ($M)14,565 · FY2025
- Short-Term Investments ($M)0 · FY2025
- Accounts Receivable, Net ($M)11,775 · FY2025
- Inventories ($M)6,658 · FY2025
- Other Current Assets ($M)10,518 · FY2025
- Total Current Assets ($M)43,516 · FY2025
- Property, Plant and Equipment (PP&E), Net ($M)25,316 · FY2025
- Goodwill ($M)21,579 · FY2025
- Other Intangibles, Net ($M)26,681 · FY2025
- Long-Term Investments ($M)956 · FY2025
- Other Noncurrent Assets ($M)18,818 · FY2025
- Trade Accounts Payable ($M)4,404 · FY2025
- Loans Payable and Current Portion of Long-Term Debt ($M)2,589 · FY2025
- Income Taxes Payable ($M)4,726 · FY2025
- Accrued and Other Current Liabilities ($M)14,468 · FY2025
- Total Current Liabilities ($M)28,327 · FY2025
- Long-Term Debt ($M)46,750 · FY2025
- Deferred Income Taxes ($M)1,439 · FY2025
- Other Noncurrent Liabilities ($M)7,688 · FY2025
- Common Stock ($M)1,788 · FY2025
- Other Paid-In Capital ($M)45,029 · FY2025
- Retained Earnings ($M)73,075 · FY2025
- Accumulated Other Comprehensive Loss ($M)-4,287 · FY2025
- Treasury Stock, at Cost ($M)-62,999 · FY2025
- Merck & Co., Inc. Stockholders' Equity ($M)52,606 · FY2025
- Noncontrolling Interests ($M)56 · FY2025
- Total Equity ($M)52,662 · FY2025
Cite this data
StockData. (2026). Merck DB Balance Sheet — Total Assets ($M) ($M), annual FY2008–FY2025 [Data set]. Compiled from Merck SEC filings and investor materials. https://stockdatahq.com/stocks/mrk/kpis/db_bal_assets
See every metric in the Merck KPI table. Data updated Oct 26, 2026.